Efficacy of factor VIII/von Willebrand factor concentrate Alphanate<sup>®</sup> in preventing excessive bleeding during surgery in subjects with von Willebrand disease
Georges‐Étienne Rivard(Centre Hospitalier Universitaire Sainte-Justine), Louis M. Aledort(Icahn School of Medicine at Mount Sinai)
Cited by 44
Related Papers
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
|The Lancet|2008|862
Definitions in Hemophilia
|Thrombosis and Haemostasis|2001|772
A longitudinal study of orthopaedic outcomes for severe factor‐VIII‐deficient haemophiliacs
|Journal of Internal Medicine|1994|613
A More Uniform Measurement of Factor VIII Inhibitors
|Thrombosis and Haemostasis|1975|587